(a)
| Case | Age/sex | Nidus | Pathologic stage before Nx (TNM) | Location of metastases | Disease state before CIK cell treatment | CIK cycles | Disease state after CIK cell treatment | Disease state by the end of followup | PFS (month) | OS (month) |
|---|---|---|---|---|---|---|---|---|---|---|
| UPN 1 | 69/M | Left | T1N0M0 | — | CR | 4 | CR | CR | 31 | 31 |
| UPN 2 | 43/M | Right | T1N0M0 | — | CR | 4 | CR | CR | 42 | 42 |
| UPN 3 | 60/M | Left | T1N0M0 | — | CR | 4 | CR | CR | 37 | 37 |
| UPN 4 | 53/M | Left | T2N0M1 | Lung | PD | 8 | PR | SD | 17 | 28 |
| UPN 5 | 61/M | Left | T1N0M0 | — | CR | 4 | CR | CR | 40 | 40 |
| UPN 6 | 57/M | Right | T2N0M1 | Lung | PD | 8 | PR | SD | 38 | 41 |
| UPN 7 | 79/F | Left | T2N1M0 | Retroperitoneal lymph nodes | PD | 8 | SD | SD | 12 | 26 |
| UPN 8 | 50/M | Right | T1N0M0 | — | CR | 5 | CR | CR | 40 | 40 |
| UPN 9 | 63/M | Right | T2N0M0 | — | CR | 4 | CR | CR | 32 | 32 |
| UPN 10 | 47/M | Left | T1N0M1 | Brain (left temporal lobe) |
PD | 12 | SD | SD | 33 | 33 |
RCC: renal cell carcinoma; CIK: cytokine-induced killer; TNM: tumornodemetastasis.